Climate Change Data

Kedrion SpA

Climate Impact & Sustainability Data (2019, 2022, 2023)

Reporting Period: 2019

Environmental Metrics

ESG Focus Areas

  • Environmental Sustainability
  • Social Responsibility
  • Employee Well-being
  • Community Investment
  • Patient Access
  • Supply Chain
  • Safety

Environmental Achievements

  • Extended EPD® certification to all products made in Bolognana plant.
  • Upgraded Bolognana plant's cogeneration system to tri-generation, increasing efficiency and decreasing pollution emissions.
  • Reached and doubled the goal of 50,000 kilometers saved through carpooling initiative.

Social Achievements

  • Launched “Heroes’ Club” for plasma donors in Hungary.
  • Organized a meeting between Hungarian plasma donors and GBS/CIDP patients.
  • Supported various community initiatives in Italy, Hungary, and the US.
  • Organized Hemophilia Care: Building Confidence congress in Trieste, Italy.
  • Supported the Worldwide Initiative for Rh disease Eradication (WIRhE).
  • Continued support for research and training in Hemophilia, Neurology, and Immunology.
  • Facilitated humanitarian donations of coagulation factors to less developed countries.

Governance Achievements

  • Attracted major investment from FSI SGR SpA and maintained stake from CDP Equity.
  • Won “Best Legal Management” award at the 2019 TopLegal Corporate Counsel & Finance Awards.
  • Resumed production at Melville plant after regulatory approvals.

Climate Goals & Targets

Medium-term Goals:
  • Launch KIg10 (10% Immunoglobulin) after clinical trials.
  • Obtain pediatric certification for KEDRAB® (Human Rabies Immunoglobulin).
Short-term Goals:
  • Full integration of Melville plant into global industrial system.

Environmental Challenges

  • Market disruption in Hemophilia A treatment due to new monoclonal therapy.
  • Regulatory hurdles for Melville plant.
  • Market-based disruptions and higher-than-normal personnel turnover at Gödöllő plant.
  • Disparities in access to treatment for Hemophilia in Latin America and other regions.
Mitigation Strategies
  • Renewed commitment to Hemophilia patients and community education.
  • Cleared regulatory hurdles and resumed production at Melville plant.
  • Implemented standardization in production processes and enhanced Kedrion quality culture at Gödöllő plant.
  • Focused on educational medical meetings and collaborations in Latin America to address access challenges.

Supply Chain Management

Responsible Procurement
  • Self-sufficiency in plasma supply through KEDPLASMA.

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

  • Goal 3: Good Health and Well-being
  • Goal 8: Decent Work and Economic Growth
  • Goal 9: Industry, Innovation and Infrastructure
  • Goal 13: Climate Action

Kedrion's initiatives contribute to these goals through the production of life-saving therapies, investment in sustainable practices, and support for community development.

Sustainable Products & Innovation

  • KIg10 (10% Immunoglobulin)
  • Plasminogen

Awards & Recognition

  • Best Legal Management award at the 2019 TopLegal Corporate Counsel & Finance Awards

Reporting Period: 2022

Environmental Metrics

Scope 1 Emissions:30,122 tCO2e
Scope 2 Emissions:35,982 tCO2e
Water Consumption:1,756,294 CBM
Waste Generated:26,858,430 kg

ESG Focus Areas

  • People
  • Social Responsibility
  • Environment

Environmental Achievements

  • Waste production decreased by 22% (Kedrion only, excluding BPL)
  • Consumption of electricity, diesel fuel, and natural gas decreased by 2% (Kedrion only, excluding BPL)

Social Achievements

  • Launched the Zero Accidents project to reduce workplace accidents to zero
  • Provided approximately 10,000 hours of training
  • Increased number of people involved in performance management from 1,932 in 2021 to 3,841 in 2022
  • Supported various local community projects and initiatives in Italy, the US, and Hungary

Governance Achievements

  • No incidents of corruption or failure to respect human rights reported in 2022

Climate Goals & Targets

Environmental Challenges

  • Increased CO2 emissions due to the acquisition of BPL and increased production
  • Finding the right talent with the required technical and scientific skills
  • Turnover rate, especially in the United States, linked to the dynamics of plasma collection centers
Mitigation Strategies
  • Implementing the Zero Accidents project
  • Investing in technical/professional training to develop technical skills
  • Using tools to foster workplace well-being, professional development, and investment in people
  • Implementing agile working model

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Risks related to the high degree of sector regulation
  • Risks related to international operations
  • Risks related to the entry of new operators in the Italian market
  • Risks related to the type of process and product and to the compliance with Good Manufacturing Practices (GMP)
  • Risks related to the operation of plants and collection centers
  • Risks related to price pressure resulting from competition and imbalances between demand and supply
  • Risks related to the development of new production processes and alternative products to plasmaderivatives
  • Risks related to IT security, management and data dissemination
  • Environmental and sustainability risks
  • Risks related to energy prices
  • Risks related to the global supply chain and the shortage of critical raw materials
Mitigation Strategies
  • The Group has developed policies, operating procedures and technical security measures to ensure adequate protection of data and corporate information. Moreover, disaster recovery and business continuity solutions have been implemented for the most important IT systems.
  • Kedrion Group operates in accordance with the environmental, social and governance sustainability standards (ESG); in particular, the Group pays significant attention to environmental protection, pursuing the objectives of reducing CO2 emissions, waste production and energy, oil and natural gas consumption.
  • The Group, through the collaboration of Procurement, Operations, Supply Chain and Quality functions, constantly tracks the supply of critical materials, and constantly evaluates the possible alternatives on the market, to mitigate the risks related to the main suppliers.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: IFRS

Certifications: Null

Third-party Assurance: PricewaterhouseCoopers SpA

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed